Pricing

Log inSign up

Cour Pharmaceuticals Development

42 people · 0 jobs
‌

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Industries

Therapeutics, Pharmaceutical

Headquarters

Elmhurst, United States

Employees

11-50

Links

Org chart

John J. Puisis
Co-Founder & President & CEO
Collapse
Brian C. Bock
CFO
PA
Pooja Agashe
Intellectual Property and Business Analyst
Lori Jester
Vice President Of Manufacturing And Supply Chain
Sarah Longoria
Chief People Officer
Dannielle Appelhans
President And Chief Executive Officer

Board & advisors

Kari Nadeau
Advisor
Ciarán P. Kelly
Advisor
John Fung
Advisor
M. Eric Gershwin
Advisor
Stephen D. Miller
Advisor
Lonnie D. Shea
Advisor

Teams

+8

Advisory and Executive Roles

12 people · 0 jobs

IK
JG
+6

Research and Development

10 people · 0 jobs

+3

Leadership Team

7 people · 0 jobs

Finance and Accounting

3 people · 0 jobs

BL
PA

Regulatory Affairs and Compliance

3 people · 0 jobs

Offices

Similar companies

Amgen

294 followers

Tango Therapeutics

3 followers

Arthritis Knee Pain Centers

2 followers

AbbVie

286 followers

Cellares

4 followers

Elanco

28 followers

AtriCure

4 followers

Abbott

399 followers

Bristol-Myers Squibb

267 followers

Gilead Sciences

164 followers

Regeneron

136 followers

Explore companies